Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.45% | 166.93 | 0.7% | $1253.55m | |
| LLY | Eli Lilly & Co. | 0.18% | 311.43 | 1.1% | $814.08m | |
| BMY | Bristol-Myers Squibb Co. | -0.73% | 70.77 | 1.0% | $778.85m | |
| PFE | Pfizer Inc. | -1.10% | 44.08 | 0.9% | $769.71m | |
| ABBV | AbbVie, Inc. | 0.04% | 143.06 | 1.9% | $735.85m | |
| MRK | Merck & Co., Inc. | -0.81% | 86.80 | 0.7% | $691.58m | |
| AZN | AstraZeneca Plc | -3.07% | 54.58 | 1.0% | $397.16m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -0.95% | 200.78 | 8.2% | $207.03m | |
| NVS | Novartis AG | -1.47% | 76.01 | 0.2% | $201.13m | |
| GBT | Global Blood Therapeutics, Inc. | 0.03% | 67.99 | 5.4% | $199.71m | |
| GSK | GSK Plc | -2.13% | 29.37 | 0.3% | $192.16m | |
| NVO | Novo Nordisk A/S | -0.40% | 97.92 | 0.1% | $170.11m | |
| HZNP | Horizon Therapeutics Plc | 0.54% | 62.97 | 5.4% | $156.21m | |
| SGEN | Seagen Inc. | -0.96% | 139.20 | 5.7% | $152.48m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.42% | 108.19 | 12.4% | $128.76m |
Company Profile
Alnylam Pharmaceuticals, Inc. is a global commercial-stage biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. Its products include ONPATTRO, GIVLAARI, and OXLUMO. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.